comparemela.com
Home
Live Updates
iGlarLixi Safe and Effective in Inadequately Controlled T2D : comparemela.com
iGlarLixi Safe and Effective in Inadequately Controlled T2D
A once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting.
Related Keywords
Qatar ,
United States ,
American ,
Rayaza Malik ,
,
Qatar Foundation ,
Research Division ,
American Diabetes ,
European Association ,
Weill Cornell Medicine Qatar ,
Education City ,
Diabetes Mellitus Type 2 ,
Iabetes Mellitus Type Ii ,
Type 2 Diabetes ,
Ype 2 Dm ,
T2dm ,
2d ,
Hypoglycemia ,
Board Certification ,
Boards ,
Oard Recertification ,
Metabolism ,
Etabolic ,
Office Visits ,
Patient Visits ,
Receptors ,
Obesity ,
Bese ,
comparemela.com © 2020. All Rights Reserved.